TickerKhojComparison · NSE · data 2026-11-02
GlaxoSmithKline Pharmaceuticals Limited vs Wockhardt Limited
In plain words
Size: GlaxoSmithKline Pharmaceuticals Limited is about 1.4 times the market value of Wockhardt Limited.
Valuation (P/E): Wockhardt Limited 75.4 vs GlaxoSmithKline Pharmaceuticals Limited 40.7.
Return on equity: GlaxoSmithKline Pharmaceuticals Limited 49.1% vs Wockhardt Limited 4.6%.
Debt to equity: Wockhardt Limited 0.45 vs GlaxoSmithKline Pharmaceuticals Limited 0.01.
Differences in the numbers, not a recommendation of either stock.
Side by side
| GLAXO | WOCKPHARMA | |
|---|---|---|
| Price | ₹2,566.8 | ₹1,898 |
| Market cap | ₹42,073 cr | ₹30,809 cr |
| P/E | 40.7 | 75.4 |
| P/B | — | — |
| ROE | 49.1% | 4.6% |
| ROCE | 52.8% | 5.3% |
| Debt / equity | 0.01 | 0.45 |
| Operating margin | 32.8% | 13.8% |
| Dividend yield | 2.30% | 0.00% |
| Sales growth, 3 years (yearly) | 5.5% | 7.8% |
| Profit growth, 3 years (yearly) | 19.3% | — |
| 1-year return | -2.5% | 47.4% |
| Revenue, last 12 months | ₹3,955 cr | ₹3,564 cr |
| Net profit, last 12 months | ₹1,068 cr | ₹409 cr |
| Latest quarter | Jun 2026 | Sept 2026 |
| Quarter net profit | ₹237 cr | ₹79 cr |
| Quarter profit vs a year earlier | +15.7% | +1.3% |
| Promoter holding | 75.00% | 49.32% |
| Health check | Strong (7/10) | Average (4.2/10) |
Common questions
Which has a higher P/E, GlaxoSmithKline Pharmaceuticals Limited or Wockhardt Limited?
Wockhardt Limited trades at the higher P/E (75.4 against 40.7). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
GlaxoSmithKline Pharmaceuticals Limited (49.1% against 4.6%).
Which carries more debt?
Wockhardt Limited has the higher debt-to-equity ratio (0.45 against 0.01).